Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KATHERINE: Trastuzumab Emtansine vs Trastuzumab in HER2+ Breast Cancer
NCT01772472Phase 3Completed
- Sponsor
- Roche
- Start
- Apr 2013
- Primary completion
- Jul 2018
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs), Small Molecules
- Countries
- 28
01
Overview
A Phase 3 trial of trastuzumab emtansine in breast cancer, sponsored by Roche. Started Apr 2013; status: completed.
02
Drugs
trastuzumab emtansine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01772472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01772472.